Other OTC - Delayed Quote • USD
Petlife Pharmaceuticals, Inc. (PTLF)
At close: April 11 at 2:46 PM EDT
Breakdown
TTM
Operating Expense
2,392.9540
Operating Income
-2,392.9540
Net Non Operating Interest Income Expense
-488.6420
Other Income Expense
-826.5630
Pretax Income
-3,708.1590
Net Income Common Stockholders
-3,708.1590
Diluted NI Available to Com Stockholders
-3,708.1590
Basic EPS
0.27
Diluted EPS
0.27
Basic Average Shares
89,312.8200
Diluted Average Shares
89,312.8200
Total Expenses
2,392.9540
Net Income from Continuing & Discontinued Operation
-3,708.1590
Normalized Income
-2,887.5980
Interest Expense
488.6420
Net Interest Income
-488.6420
EBIT
-3,219.5170
EBITDA
-3,219.5170
Net Income from Continuing Operation Net Minority Interest
-3,708.1590
Total Unusual Items Excluding Goodwill
-820.5610
Total Unusual Items
-820.5610
Normalized EBITDA
-2,398.9560
-
Yahoo Finance Plus Essential access required. Unlock Access